Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumour Response,”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT02732860
What this trial is testing

Personalized Patient Derived Xenograft (pPDX) Modeling to Test Drug Response in Matching Host

Who this might be right for
Colorectal NeoplasmsColorectal CancerBreast Cancer+3 more
University Health Network, Toronto 120
Testing effectiveness (Phase 2)Study completedNCT01973660
What this trial is testing

PAM50 HER2-enriched Phenotype as a Predictor of Response to Dual HER2 Blockade in HER2-positive Early Breast Cancer

Who this might be right for
Breast Cancer
SOLTI Breast Cancer Research Group 151
Not applicableStudy completedNCT01544686
What this trial is testing

Antimicrobial Catheter Securement Dressings for the Prevention of Cvc-related Bloodstream Infections in Cancer Patients

Who this might be right for
Bloodstream Infection
University of Cologne 630
Testing effectiveness (Phase 2)Ended earlyNCT03029611
What this trial is testing

IGFBP-2 Vaccine and Combination Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Undergoing Surgery

Who this might be right for
Stage III Fallopian Tube CancerStage III Ovarian CancerStage III Primary Peritoneal Cancer+12 more
University of Washington 11
Not applicableUnknownNCT01357733
What this trial is testing

Interim FDG PET/CT in Diffuse Large B Cell Lymphoma (DLBCL) Patients

Who this might be right for
Lymphoma, Large B-Cell, Diffuse
The Catholic University of Korea 53
Not applicableLooking for participantsNCT06876532
What this trial is testing

Evaluation of the Inflammation-based Index as a Predictive Marker of Clinical and Radiological Response in Patients Treated With Lu-177 Oxodotreotide for Intestinal Neuroendocrine Tumour

Who this might be right for
Intestinal Neuroendocrine Tumor
Institut Claudius Regaud 150
Early research (Phase 1)UnknownNCT05160714
What this trial is testing

Individualized Response-adaptive Radiation Dose Prescription in HNC Based on MRI

Who this might be right for
Head and Neck Cancer
University Hospital Tuebingen 24
Not applicableStudy completedNCT00392938
What this trial is testing

Carbon-11 Acetate and Fludeoxyglucose F 18 PET Scan of the Bone in Patients With Metastatic Prostate Cancer That Has Spread to the Bone

Who this might be right for
Metastatic CancerProstate Cancer
University of Washington 11
Not applicableLooking for participantsNCT05412758
What this trial is testing

Augmented Response of Volatile Biomarkers in Assessment of Oesophagogastric Cancer (AROMA 1 / BIORESOURCE)

Who this might be right for
Volatile Organic CompoundsMicrobiomeMicrobioata+7 more
Imperial College London 648
Testing effectiveness (Phase 2)Study completedNCT01294306
What this trial is testing

MK2206 and Erlotinib Hydrochloride in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Progressed After Previous Response to Erlotinib Hydrochloride Therapy

Who this might be right for
Adenosquamous Lung CarcinomaBronchioloalveolar CarcinomaLarge Cell Lung Carcinoma+3 more
National Cancer Institute (NCI) 80
Not applicableLooking for participantsNCT06862934
What this trial is testing

Liver Transplantation for Unresectable Intrahepatic Colangiocarcinoma After Sustained Response to Neoadjuvant Treatments

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 14
Not applicableLooking for participantsNCT07514052
What this trial is testing

Predicting Response to Selinexor-Based Therapy in Relapsed/Refractory Multiple Myeloma: A Multicenter Prospective Study

Who this might be right for
Multiple Myeloma of Bone
Shanxi Bethune Hospital 127
Testing effectiveness (Phase 2)Active Not RecruitingNCT03653052
What this trial is testing

Do Changes in ctDNA Predict Response for Patients With Oesophageal Cancer Receiving Durvalumab

Who this might be right for
Oesophageal Cancer
Simon C Pacey, MD 18
Large-scale testing (Phase 3)UnknownNCT05701436
What this trial is testing

Applicability of 3D-HDRA in Patients With Primary Liver Cancer: A Randomized Controlled Trial

Who this might be right for
Liver, Cancer of, Primary Resectable
Zhujiang Hospital 144
Not applicableUnknownNCT02063633
What this trial is testing

PET With Respiratory Gating Technique in Evaluation of Response and Normal Tissue Effect in Thoracic Cancer

Who this might be right for
To Correlate RPM Respiratory-gating Methods Analyses, Treatment Response, and Normal Tissue Metabolic Effect.Application in Clinical Outcomes and Prediction of Prognosis.
Far Eastern Memorial Hospital 30
Early research (Phase 1)WithdrawnNCT04054752
What this trial is testing

Vaccine Response With NT-I7

Who this might be right for
Breast CarcinomaColorectal AdenocarcinomaBladder Carcinoma
National Cancer Institute (NCI)
Not applicableStudy completedNCT00483821
What this trial is testing

A Retrospective Analysis of Neck Dissection Following Complete Response to Chemoradiation in HNSCC

Who this might be right for
Head and Neck Cancer
Vanderbilt-Ingram Cancer Center 165
Not applicableActive Not RecruitingNCT02386709
What this trial is testing

Study Evaluating the Utility of 18F-FDG PET in Assessing Early Response to Neoadjuvant Chemotherapy in Patients With Mammary Gland Cancer

Who this might be right for
FDG PET
Centre Georges Francois Leclerc 275
Early research (Phase 1)Not Yet RecruitingNCT07841002
What this trial is testing

CLL-1-Targeted In Vivo CAR-T Cell Immunotherapy for Relapsed/Refractory Acute Myeloid Leukemia

Who this might be right for
Relapsed/Refractory Acute Myeloid Leukemia (AML)Acute Myeloid Leukemia (AML)
Liping Dou 12
Not applicableEnded earlyNCT02145390
What this trial is testing

Chemoradiation for Bladder Preservation After Complete Response to Neoadjuvant Chemotherapy

Who this might be right for
Bladder CancerBladder CarcinomaTransition Cell Cancer+1 more
University of Miami 1
Next Page